Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use

被引：9

作者：

Lesieur, Auriane ^{[1
]}

Thomas, Xavier ^{[2
]}

Nibourel, Olivier ^{[1
,3
]}

Boissel, Nicolas ^{[4
]}

Fenwarth, Laurene ^{[1
,3
]}

De Botton, Stephane ^{[5
]}

Fournier, Elise ^{[1
,3
]}

Celli-Lebras, Karine ^{[4
]}

Raffoux, Emmanuel ^{[4
]}

Recher, Christian ^{[6
]}

Lambert, Juliette ^{[7
]}

Berthon, Celine ^{[3
,8
]}

Pigneux, Arnaud ^{[9
]}

Itzykson, Raphael ^{[4
]}

Turlure, Pascal ^{[10
]}

Pautas, Cecile ^{[11
]}

Vargaftig, Jacques ^{[12
]}

Preudhomme, Claude ^{[1
,3
]}

Dombret, Herve ^{[4
]}

Duployez, Nicolas ^{[1
,3
]}

机构：

[1] CHU Lille, Lab Hematol, Lille, France

[2] Lyon Sud Univ Hosp, Hosp Civils Lyon, Dept Hematol, Lyon, France

[3] Univ Lille, Canther Canc Heterogene Plast & Resistance Therap, Inst Rech Canc Lille, CHU Lille,Inserm,CNRS,UMR9020,UMR S 1277, Lille, France

[4] Univ Paris, St Louis Res Inst, St Louis Hosp, Dept Hematol,AP HP, Paris, France

[5] Gustave Roussy Inst, Dept Hematol, Villejuif, France

[6] Toulouse Canc Univ Inst, Dept Hematol, Toulouse, France

[7] CH Versailles, Dept Hematol, Le Chesnay, France

[8] CHU Lille, Dept Clin Hematol, Lille, France

[9] Bordeaux Haut Leveque Univ Hosp, Dept Hematol, Pessac, France

[10] Univ Limoges, CHU Limoges, Dept Hematol, Limoges, France

[11] Henri Mondor Hosp, AP HP, Dept Hematol, Creteil, France

[12] Rene Huguenin Hosp, Curie Hosp, St Cloud, France

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 06期

关键词：

NUCLEOPHOSMIN; AML;

D O I：

10.3324/haematol.2020.260133

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1767 / 1769

页数：3

共 50 条

[41] Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1):: Comparison with WT1 gene expression
Barragan, Eva
Pajuelo, Juan C.
Ballester, Sandra
Fuster, Oscar
Cervera, Jose
Moscardo, Federico
Senent, Leonor
Such, Esperanza
Sanz, Miguel A.
Bolufer, Pascual
CLINICA CHIMICA ACTA, 2008, 395 (1-2) : 120 - 123
[42] Monitoring of minimal residual disease by q-PCR in AML patients carrying NPM1 mutations
Blau, O.
Sindram, A.
Burmeister, T.
Graul, K.
Seyde, C.
Thiel, E.
Blau, I. W.
ONKOLOGIE, 2010, 33 : 233 - 233
[43] The Clinical Impact of NPM1 Mutations and the Effect of Concurrent Mutations in Acute Myeloid Leukemia: Unraveling the Prognostic Significance
Moassass, Faten
Moualla, Yahia
AL-Halabi, Bassel
Khamis, Atieh
Al-achkar, Walid
HEALTH SCIENCE REPORTS, 2024, 7 (12)
[44] Clinical decision making in chronic myeloid leukemia based on polymerase chain reaction analysis of minimal residual disease
Goldman, JM
Kaeda, JS
Cross, NCP
Hochhaus, A
Hehlmann, R
BLOOD, 1999, 94 (04) : 1484 - 1486
[45] A NOVEL MGB PROBE-BASED ASSESSMENT OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA CARRYING NPM1 (NUCLEOPHOSMIN) EXON 12 MUTATIONS
Dvorakova, D.
Ohlidalova, D.
Pospisilova, J.
Lengerova, M.
Mayer, J.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 227 - 227
[46] Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay
Goh, Hyun-Gyung
Lin, Min
Fukushima, Takashi
Saglio, Giuseppe
Kim, Dongho
Choi, Soo-Young
Kim, Soo-Hyun
Lee, Jeong
Lee, Young-Seok
Oh, Sang-Mi
Kim, Dong-Wook
LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 896 - 904
[47] Minimal Residual Disease (MRD) Monitoring in NPM1 Mutated Acute Myeloid Leukemia (AML): Impact of Concurrent FLT3-ITD and DNMT3A Mutations on MRD Kinetics and Clinical Outcome
Kapp-Schwoerer, Silke
Kroenke, Jan
Corbacioglu, Andrea
Gaidzik, Verena I.
Paschka, Peter
Eiwen, Karina
Spaeth, Daniela
Goehring, Gudrun
Schlegelberger, Brigitte
Luebbert, Michael
Kindler, Thomas
Wattad, Mohammed
Germing, Ulrich
Nachbaur, David
Fiedler, Walter
Thol, Felicitas
Heuser, Michael
Krauter, Juergen
Ganser, Arnold
Schlenk, Richard F.
Doehner, Hartmut
Doehner, Konstanze
BLOOD, 2013, 122 (21)
[48] MOLECULAR MINIMAL RESIDUAL DISEASE MONITORING IN NPM1-MUTATED ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE
Cesini, L.
Minotti, C.
Capria, S.
Trisolini, S. M.
Diverio, D.
Fegatelli, D. Alunni
Cartoni, C.
Breccia, M.
Latagliata, R.
Ciotti, G.
Tartaglia, G.
Marziali, M.
Colafigli, G.
Carmosino, I.
Martelli, M.
HAEMATOLOGICA, 2020, 105 : S87 - S88
[49] Biological and clinical influences of NPM1 in acute myeloid leukemia patients with DNMT3A mutations
Yang, Xinrui
Shi, Jinlong
Zhang, Xinpei
Zhang, Gaoqi
Zhang, Jilei
Yang, Siyuan
Wang, Jing
Ke, Xiaoyan
Fu, Lin
CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 2489 - 2497
[50] NPM1 Minimal Residual Disease As Prognostic and Predictive Factor in Young Adults with Acute Myeloid Leukemia: a Study By the French ALFA Group
Balsat, Marie
Renneville, Aline
Thomas, Xavier
Marceau, Alice
De Botton, Stephane
Nibourel, Olivier
Raffoux, Emmanuel
Rodriguez, Celine
Cayuela, Jean-Michel
Hayette, Sandrine
Terre, Christine
Celli-Lebras, Karine
Dombret, Herve
Preudhomme, Claude
Boissel, Nicolas
BLOOD, 2015, 126 (23)

← 1 2 3 4 5 →